Jecheskiel Gonczarowski
Amministratore Delegato presso D.S.N.I. Investments Ltd.
Profilo
Jecheskiel Gonczarowski is the founder of Getter Group Ltd.
He is currently the Chairman & Chief Executive Officer of D.S.N.I.
Investments Ltd.
Jecheskiel's former positions include Director at Rotshtein RealEstate Ltd.
from 1982 to 2010 and Independent Non-Executive Director at Vascular Biogenics Ltd.
Posizioni attive di Jecheskiel Gonczarowski
| Società | Posizione | Inizio |
|---|---|---|
| D.S.N.I. Investments Ltd. | Amministratore Delegato | 01/01/2010 |
Precedenti posizioni note di Jecheskiel Gonczarowski
| Società | Posizione | Fine |
|---|---|---|
| ROTSHTEIN REALESTATE LTD | Direttore/Membro del Consiglio | 01/01/2010 |
Getter Group Ltd.
 Getter Group Ltd. Electronics DistributorsDistribution Services Getter Group Ltd. engages in the representation of international brands in Israel and abroad. Its services include marketing, distribution, and provision of support services for products and solutions in the fields of printing, medical equipment, electronics, communication, infrastructure, computers, toys, photography, and transportation equipment. The company was founded by Jecheskiel Gonczarowski in 1955 and is headquartered in Petach-Tikva, Israel. | Fondatore | - |
| NOTABLE LABS, LTD. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ROTSHTEIN REALESTATE LTD | Industrial Services |
| Aziende private | 3 |
|---|---|
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
| D.S.N.I. Investments Ltd. | |
Getter Group Ltd.
Getter Group Ltd. Electronics DistributorsDistribution Services Getter Group Ltd. engages in the representation of international brands in Israel and abroad. Its services include marketing, distribution, and provision of support services for products and solutions in the fields of printing, medical equipment, electronics, communication, infrastructure, computers, toys, photography, and transportation equipment. The company was founded by Jecheskiel Gonczarowski in 1955 and is headquartered in Petach-Tikva, Israel. | Distribution Services |
- Borsa valori
- Insiders
- Jecheskiel Gonczarowski
